Atricure Inc. Stock
Atricure Inc. Stock
Atricure Inc. took a tumble today and lost -€1.000 (-3.140%).
Atricure Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
With a target price of 46 € there is a positive potential of 49.35% for Atricure Inc. compared to the current price of 30.8 €.
Pros and Cons of Atricure Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atricure Inc. | -3.140% | -5.521% | -7.229% | -50.323% | -9.412% | -50.323% | -36.885% |
| SI-BONE Inc | -0.720% | -4.861% | -17.964% | -15.432% | -18.935% | - | - |
| Orasure Tech | 0.000% | 1.754% | 14.851% | -38.947% | 12.621% | -51.667% | -81.732% |
| Lantheus Holdings Inc | -1.520% | -1.191% | -1.776% | -36.700% | -1.399% | 0.714% | - |
Comments
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
News
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Sven Wehrwein, a member of the Board of Directors at AtriCure (NASDAQ:ATRC), exercised 10,000 non-qualified stock options and immediately sold the underlying shares in derivative transactions on
